Jiangsu Kanion Pharmaceutical Co Ltd
SSE:600557
Wall Street
Price Targets
Price Targets Summary
Jiangsu Kanion Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for
Jiangsu Kanion Pharmaceutical Co Ltd
is 21.66 CNY
with a low forecast of 21.45 CNY and a high forecast of 22.3 CNY.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Jiangsu Kanion Pharmaceutical Co Ltd's stock price target?
Price Target
21.66
CNY
According to Wall Street analysts, the average 1-year price target for
Jiangsu Kanion Pharmaceutical Co Ltd
is 21.66 CNY
with a low forecast of 21.45 CNY and a high forecast of 22.3 CNY.
What is Jiangsu Kanion Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
4%
For the last 13 years the
compound annual growth rate for
Jiangsu Kanion Pharmaceutical Co Ltd's revenue is
7%.
The projected
CAGR
for the next 3 years is
4%.
What is Jiangsu Kanion Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
8%
For the last 13 years the
compound annual growth rate for
Jiangsu Kanion Pharmaceutical Co Ltd's operating income is
4%.
The projected
CAGR
for the next 3 years is
8%.
What is Jiangsu Kanion Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
10%
For the last 13 years the
compound annual growth rate for
Jiangsu Kanion Pharmaceutical Co Ltd's net income is
6%.
The projected
CAGR
for the next 3 years is
10%.
